ATG Plus PTCy vs ATG for CGVHD Prophylaxis

NCT04202835 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Acute Leukemia
Myelodysplasia
Chronic Graft-versus-host-disease

Interventions

DRUG: Cyclophosphamide
DRUG: Anti-Thymocyte globulin (rabbit)

Sponsor

McMaster University

Collaborators

[object Object]
[object Object]
[object Object]